NLRP3 and colitis: Collectively, these findings demonstrate that isobutyric acid, a microbiota-derived SCFA, plays a pivotal role in suppressing NLRP3 inflammasome overactivation and mediates the protective effects of Lac16 against colitis pathogenesis.